A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
A phase 1/2 trial of REGN7075, Cemiplimab, Bevacizumab and Trifluridine/tipiracil in advanced solid tumours, run by Regeneron Pharmaceuticals, active and no longer recruiting.
Overview
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers is a phase 1/2 interventional study registered as NCT04626635 by Regeneron Pharmaceuticals, with 548 participants enrolled, started 2020-12-21 and due to reach its primary completion in 2026-11-13. Interventions recorded: REGN7075, Cemiplimab, Platinum-based doublet chemotherapy, Bevacizumab and Trifluridine-tipiracil.
Similar pages
not linked directly; found by shared links- TrialA Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- TrialA Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
Shares Cemiplimab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Shares Trifluridine/tipiracil, Bevacizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
Shares Bevacizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialS-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
Shares Bevacizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
Shares Bevacizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody
Shares Cemiplimab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors
Shares Bevacizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.